{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Antidiabetic", "Diabetes mellitus", "Galvus met\u00ae", "Insulin", "Lipid profile", "Selenium cleome droserifolia nanoparticles"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "33183567", "DateCompleted": {"Year": "2021", "Month": "09", "Day": "24"}, "DateRevised": {"Year": "2021", "Month": "09", "Day": "24"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "08", "Day": "18"}], "Language": ["eng"], "ELocationID": ["10.1016/j.clnesp.2020.07.016", "S2405-4577(20)30163-7"], "Journal": {"ISSN": "2405-4577", "JournalIssue": {"Volume": "40", "PubDate": {"Year": "2020", "Month": "Dec"}}, "Title": "Clinical nutrition ESPEN", "ISOAbbreviation": "Clin Nutr ESPEN"}, "ArticleTitle": "Selenium\u00a0cleome droserifolia\u00a0nanoparticles (Se-CNPs) and it's ameliorative effects in experimentally induced diabetes mellitus.", "Pagination": {"StartPage": "383", "EndPage": "391", "MedlinePgn": "383-391"}, "Abstract": {"AbstractText": ["Diabetes mellitus is a group of metabolic disorders with great challenge in its treatment due to its pathological complication. In recent decade, there is extensive use of applying nanotechnology to medicinal plants as a trend in diabetes treatment due to phytochemical constituents. The present study aimed to evaluate the hypoglycemic effect of selenium cleome droserifolia nanoparticles (Se-CNPs) and/or Galvus met\u00ae treatment on streptozotocin induced diabetes mellitus in male rats. Fifty male Wistar rats were divided equally into five groups: control group, control diabetic group, diabetic group treated with Se-CNPs, diabetic group treated with Galvus met\u00ae and diabetic group treated with Se-CNPs plus Galvus met\u00ae. Glucose and insulin levels, Alanine Aminotransferase (ALT) and Aspartate Aminotransferase (AST), Total Cholesterol (TC), Triacylglycerols (TG), High Density Lipoprotein (HDL-c), Very Low Density Lipoprotein cholesterol (VLDL-c), Low Density Lipoprotein cholesterol (LDL-c) and (NEFAs), urea and creatinine were evaluated. Also, histopathological changes in pancreatic tissue were examined. The results showed significant elevation in serum glucose concentration, ALT and AST activities, TG, LDL-c, VLDL-c and Non Esterified Fatty Acids (NEFAs), urea and creatinine levels while a significant decrease in serum insulin and HDL-c concentration in untreated diabetic rats when compared with control. Meanwhile, daily administration of Se-CNPs and/or Galvus met\u00ae to diabetic rats showed significant amelioration of these parameters."], "CopyrightInformation": "Copyright \u00a9 2020 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Benha University, Egypt."}], "LastName": "Abdel Maksoud", "ForeName": "H A", "Initials": "HA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Benha University, Egypt."}], "LastName": "Abou Zaid", "ForeName": "Omayma A R", "Initials": "OAR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Basic Medical Sciences, Shaqra University, Saudi Arabia. Electronic address: al_harrif@yahoo.com."}], "LastName": "Elharrif", "ForeName": "Mohamed G", "Initials": "MG"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Benha University, Egypt."}], "LastName": "Omnia", "ForeName": "M A", "Initials": "MA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Benha University, Egypt."}], "LastName": "Alaa", "ForeName": "E A", "Initials": "EA"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Clin Nutr ESPEN", "NlmUniqueID": "101654592", "ISSNLinking": "2405-4577"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Blood Glucose"}, {"RegistryNumber": "H6241UJ22B", "NameOfSubstance": "Selenium"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Blood Glucose"}, {"QualifierName": [], "DescriptorName": "Cleome"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Diabetes Mellitus, Experimental"}, {"QualifierName": [], "DescriptorName": "Nanoparticles"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Wistar"}, {"QualifierName": [], "DescriptorName": "Selenium"}], "CoiStatement": "Declaration of Competing Interest The authors declare that they have no competing interests."}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2020", "Month": "6", "Day": "6"}, {"Year": "2020", "Month": "7", "Day": "22"}, {"Year": "2020", "Month": "7", "Day": "26"}, {"Year": "2020", "Month": "11", "Day": "13", "Hour": "5", "Minute": "34"}, {"Year": "2020", "Month": "11", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "9", "Day": "25", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["33183567", "10.1016/j.clnesp.2020.07.016", "S2405-4577(20)30163-7"]}}]}